Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
21.92
-0.55 (-2.47%)
At close: Apr 28, 2026, 4:00 PM EDT
21.92
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $1.44 billion as of April 28, 2026. Its market cap has increased by 159.31% in one year.
Market Cap
1.44B
Enterprise Value
1.02B
1-Year Change
159.31%
Ranking
Category
Stock Price
$21.92
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $1.44B, an increase of 54.02%. That is a compound annual growth rate of 30.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.47B | 59.59% |
| Dec 31, 2025 | 921.98M | -2.74% |
| Dec 31, 2024 | 947.92M | 1.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immatics | 1.52B |
| MBX Biosciences | 1.52B |
| Damora Therapeutics | 1.49B |
| Immunocore Holdings | 1.49B |
| Biohaven | 1.49B |
| Agios Pharmaceuticals | 1.48B |
| Precigen | 1.46B |
| Ardelyx | 1.46B |